Tilray Inc (TLRY)
$19.75 1.42 (6.71%)
19:59 EST TLRY Stock Quote Delayed 15 Minutes
Previous Close $19.75
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 4.33M
Day's Range 19.38 - 21.45
52-Week Range 15.01 - 89.88
Dividend & Yield N/A (N/A)
TLRY Stock Predictions, Articles, and Tilray Inc News
- From InvestorPlace
- From the Web
Among the marijuana losers of 2019, Tilray stock was one of the ugliest. However, with executive-level recruitments, along with a clearer roadway, this name can surprise investors.
After an unrelenting decline since the start of 2019, Aurora Cannabis (NYSE:ACB) may continue its dramatic drop in 2020. The sudden executive changes, a stock....
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
TLRY stock is down big since the passage of the MORE Act, and that's a sign of more troubles to come for Tilray stock.
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
When pot stocks failed to live up to heightened expectations, investors panicked out of the sector. However, the selloff has probably gone on far too long, suggesting a possible comeback.
With some recent bullish moves, Aurora Cannabis stock looks interesting as a contrarian trade. However, it has much to prove before anyone can offer a confident recommendation.
These stocks to sell will likely face pain in 2020 as these equities face worsening conditions and increasing financial and market pressure.
Hope for U.S. legalization helped Tilray stock, but financial conditions indicate it may struggle to remain top-tier or perhaps, survive.
Despite the steep discount in Tilray stock, this remains a name to avoid because neither the fundamentals nor technicals imply a positive trajectory.
Canopy Growth faces plenty of tough problems ahead. So too, do its competitors. When will outsized growth return to CGC?
By Thomas Niel
Tilray stock is a minefield of risk. "Cannabis 2.0" could improve their fortunes. But a myriad of risks remain. With $450 million in convertible notes coming due in 2023, TLRY needs to improve its cash situation. Unless the company is swimming in green (cash, not pot) by then, Tilray will need a capital infusion to stay afloat. Add in potential selling pressure from Privateer shareholders unloading their position, and there's too many fleas on this dog for my taste.
Tilray’s acquisition of Manitoba Harvest should help Tilray stock. TLRY stock may perform better than other marijuana stocks.
Walmart and Cisco stock beat on earnings, but fell on Thursday. Here's what happened in the stock market today.
Investors justifiably have low expectations for TLRY stock ahead of quarterly earnings. Here's the outlook for Tilray through the end of 2019.
Tilray stock is hovering near its IPO level. The cannabis bubble has burst, but that doesn't mean TLRY should be treated like a penny stock.
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.
From The Motley Fool
From Market News Video
Navellier RatingsPowered by Portfolio Grader